committee under the chairmanship of NITI Aayog member Dr VK Paul will meet
on Wednesday to consider the logistics and ethical aspects of procuring and administering the
19 vaccine, the Union Health Ministry said
on vaccine administration will engage with all the stakeholders including state governments and vaccine manufacturers, the ministry said in a tweet.
committee would chalk out strategies
on the aspects of prioritisation of the vaccine administration once it is developed, rollout and cold chain logistics and training of the people who would be administering it.
on Vaccine Administration under the chairmanship of Dr V K Paul, NITI Aayog will meet
on 12th August to consider logistics & ethical aspects of procurement & administration of
19 vaccine,” the ministry tweeted.
The phase-1 human clinical trials of the two
19 vaccine candidates, developed indigenously by Bharat Biotech in collaboration with the Indian Council of Medical Research and Zydus Cadila Ltd, have been completed and the trials have moved to phase 2, ICMR Director General Balram Bhargava said last Tuesday.
The Serum Institute of India, Pune has also been permitted for conducting Phase 2 and 3 human clinical trials of the Oxford University-developed
19 vaccine candidate in the country.
19 caseload has climbed to 22,68,675 while the death-toll mounted to 45,257, according to the Health ministry data updated at 8 am